Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

176.08
+0.42500.24%
Volume:585.44K
Turnover:103.45M
Market Cap:23.63B
PE:-50.25
High:179.39
Open:175.00
Low:174.00
Close:175.65
52wk High:179.39
52wk Low:53.40
Shares:134.20M
Float Shares:129.78M
Volume Ratio:0.95
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-106.02
PE(LYR):-53.03

Loading ...

Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate MAT2203 to Azurity Pharmaceuticals

GlobeNewswire
·
Jul 13

S&P 500 Futures Flat in Premarket Trading; Circle Internet Group, Moog Lead

Dow Jones
·
Jul 10

Cancer Blood Screen Spac's Merger is Delayed by Test's Results

Dow Jones
·
Jul 10

Guardant Health to Report Q2 2026 Results After Market Close, Host Conference Call

Reuters
·
Jul 10

Guardant Health is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jul 10

Movement Alert|Guardant Health Rises 5.21% in Regular Trading, BofA Raises Price Target to $190

Market Focus
·
Jul 09

Guardant Health price target raised to $175 from $130 at Morgan Stanley

TIPRANKS
·
Jul 09

Guardant Health is Maintained at Buy by Citigroup

Dow Jones
·
Jul 09

Guardant Health price target raised to $215 from $150 at Citi

TIPRANKS
·
Jul 08

BofA Securities Adjusts Price Target on Guardant Health to $190 From $135

MT Newswires Live
·
Jul 06

Guardant Health is Maintained at Buy by B of a Securities

Dow Jones
·
Jul 06

Guardant Health price target raised to $190 from $135 at BofA

TIPRANKS
·
Jul 06

Guardant Health (GH) Is Up 12.6% After India Shield Cancer Test Deal And UnitedHealth Coverage Expansion

Simply Wall St.
·
Jul 05

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Guardant Health (GH)

TIPRANKS
·
Jul 03

Zydus Lifesciences Signs Mou with Apollo Hospitals

Reuters
·
Jul 03

Guardant Health: Buy Rating Reaffirmed as UnitedHealth Coverage Expands Shield Access; 12-Month Price Target Maintained at $165

TIPRANKS
·
Jul 02

Guardant news ‘meaningful positive’ but impact modest, says TD

TIPRANKS
·
Jul 02

When Multi-cancer Blood Screens Could Finally Take Off

Dow Jones
·
Jul 02

Unitedhealth Group NOW Covers Guardant Health’s Shield Blood Test for Colorectal Cancer Screening

THOMSON REUTERS
·
Jul 02

Guardant Health Rises on Unitedhealth Coverage Boost for Colorectal Cancer Kit

Reuters
·
Jul 02